However, dulaglutide demonstrated a notable benefit by preventing the typical weight gain associated with quitting smoking, and participants receiving dulaglutide also experienced a significant reduction in HbA1c levels (Lengsfeld et al., 2023)
For patients with a history of heart disease, Ozempics cardioprotective effects can be a deciding factor
According to SURMOUNT 5 clinical trial, people taking tirzepatide lost an average of 20.2% of their body weight, while those taking semaglutide lost 13.7% after 72 weeks
The inclusion of benzyl alcohol in bacteriostatic water provides antimicrobial properties that inhibit bacterial growth in multi-use laboratory environments
The choice between these medications depends on your lifestyle preferences, response patterns, and whether a dual-pathway approach (GLP-1 and GIP) versus single-pathway therapy aligns with your goals